Vahanian Alec, Himbert Dominique, Brochet Eric
Cardiology Department, Bichat Hospital, University Paris VII, Paris, France.
EuroIntervention. 2015 Sep;11 Suppl W:W14-6. doi: 10.4244/EIJV11SWA3.
Patients with multiple valve disease are a frequent and heterogeneous entity whose evaluation and management are challenging. The assessment of the severity requires a cautious integrative evaluation. The indications for intervention are based on global assessment of the consequences of the disease, mainly based on symptoms, pulmonary hypertension, and left ventricular dysfunction. The decision to intervene should also take into account the inherent additional risk. Percutaneous intervention in this population is in its infancy but the future development of transcatheter techniques will be of interest in this high-risk cohort and will offer the possibility of tailored and staged procedures.
患有多种瓣膜疾病的患者是一个常见且异质性的群体,对其进行评估和管理具有挑战性。严重程度的评估需要谨慎的综合评估。干预指征基于对疾病后果的全面评估,主要依据症状、肺动脉高压和左心室功能障碍。干预决策还应考虑到固有的额外风险。该人群的经皮干预尚处于起步阶段,但经导管技术的未来发展将受到这一高风险队列的关注,并将提供定制化和分阶段手术的可能性。